SG Americas Securities
AKYA

SG Americas Securities’s Akoya BioSciences AKYA Stock Holding History

SG Americas Securities’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,362
Closed -$16K – 2898
2025
Q1 		$16K Sell
11,362
-963
-8% -$2.11K ﹤0.01% 3390
2024
Q4 		$28K Buy
+12,325
New +$32.6K ﹤0.01% 2978
2021
Q4 		– Sell
-8,713
Closed -$122K – 3348
2021
Q3 		$122K Sell
8,713
-5,043
-37% -$84.3K ﹤0.01% 3571
2021
Q2 		$266K Buy
+13,756
New +$284K ﹤0.01% 2216

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCA
Peddock Capital Advisors Braintree, Massachusetts $501M AUM 29.8% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SG Americas Securities's AKYA Position: Q2 2025 in Review

SG Americas Securities sold out of Akoya BioSciences (AKYA) in Q2 2025, closing a stake of 11,362 shares — an estimated $16K sold.

SG Americas Securities first reported a position in AKYA in Q2 2021 and held it in 4 quarters. The position peaked at $266K in Q2 2021. 58 funds tracked by Wall St. Rank hold AKYA as of Q2 2025.

  • SG Americas Securities reported no remaining Akoya BioSciences position as of Q2 2025 after selling out during the quarter.
  • SG Americas Securities sold 11,362 Akoya BioSciences shares in Q2 2025, an estimated $16K.
  • SG Americas Securities first reported a position in Akoya BioSciences in Q2 2021 and held it in 4 quarters.
  • SG Americas Securities's Akoya BioSciences position peaked at $266K in Q2 2021.
  • 58 funds tracked by Wall St. Rank held Akoya BioSciences as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.